Eton Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:ETON) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 516 K-765 K2.09 M7.96 M12.03 M 21.31 M Cash from investing activities 038.13 M00284 K 38.42 M Cash from financing activities 385 K31.61 M394 K00 32.01 M Free cash flow 516 K-8.9 M2.09 M7.96 M11.74 M 12.89 M

Новости

Пероральный раствор DESMODA получил одобрение FDA для лечения несахарного диабета

DESMODA oral solution receives FDA approval for diabetes insipidus

Акции Eton Pharmaceuticals растут после лицензирования препарата

Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug

Eton Pharmaceuticals лицензирует препарат для сверхредкого заболевания

Eton Pharmaceuticals licenses ultra-rare disease treatment candidate

Implied Volatility Surging for Eton Pharmaceuticals Stock Options

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals: доходы оказались ниже прогнозов, прибыльa обогнал ожидания в Q3

Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday

Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold